The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications

被引：0
|
作者：
Steffen M. Heckl
Viva Wiesener
Hans-Michael Behrens
Dita Ulase
Sandra Krüger
Christoph Röcken
机构：
[1] Christian-Albrechts-University,Department of Pathology
[2] University Hospital Schleswig–Holstein,Department of Internal Medicine I
[3] Riga Stradins University,Department of Pathology
来源：
Gastric Cancer | 2019年 / 22卷
关键词：
Gastric cancer; Insulin receptor; HER-2 Proto-Oncogene Protein; Prognosis; Cancer treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1130 / 1142
页数：12
相关论文
共 50 条
  • [41] A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status
    Bria, E.
    De Manzoni, G.
    Beghelli, S.
    Tomezzoli, A.
    Barbi, S.
    Di Gregorio, C.
    Scardoni, M.
    Amato, E.
    Frizziero, M.
    Sperduti, I.
    Corbo, V.
    Brunelli, M.
    Bersani, S.
    Tortora, G.
    Scarpa, A.
    ANNALS OF ONCOLOGY, 2013, 24 (03) : 693 - 701
  • [42] Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients
    Miaozhen Qiu
    Yixin Zhou
    Xinke Zhang
    Zixian Wang
    Fang Wang
    Jianyong Shao
    Jiabin Lu
    Ying Jin
    Xiaoli Wei
    Dongsheng Zhang
    Fenghua Wang
    Yuhong Li
    Dajun Yang
    Ruihua Xu
    BMC Cancer, 14
  • [43] Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis
    H. Jiang
    Q. Li
    S. Yu
    Y. Yu
    Y. Wang
    W. Li
    Y. Cui
    T. Liu
    Clinical and Translational Oncology, 2017, 19 : 197 - 203
  • [44] Temporal heterogeneity of HER2 expression in metastatic gastric cancer: a case report
    Qi Zhang
    Tao Yu
    Zhicheng Zhao
    Shiyao Zhang
    Qianpeng Huang
    Gang Liu
    World Journal of Surgical Oncology, 20
  • [45] Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis
    Jiang, H.
    Li, Q.
    Yu, S.
    Yu, Y.
    Wang, Y.
    Li, W.
    Cui, Y.
    Liu, T.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (02) : 197 - 203
  • [46] Temporal heterogeneity of HER2 expression in metastatic gastric cancer: a case report
    Zhang, Qi
    Yu, Tao
    Zhao, Zhicheng
    Zhang, Shiyao
    Huang, Qianpeng
    Liu, Gang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [47] HER2 Inhibition in Gastric Cancer-Novel Therapeutic Approaches for an Established Target
    Fong, Caroline
    Chau, Ian
    CANCERS, 2022, 14 (15)
  • [48] HER2 expression in gastric and oesophageal cancer: a meta-analytic review
    Nagaraja, Vinayak
    Eslick, Guy D.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 6 (02) : 143 - 154
  • [49] Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites
    Gumusay, Ozge
    Benekli, Mustafa
    Ekinci, Ozgur
    Baykara, Meltem
    Ozet, Ahmet
    Coskun, Ugur
    Demirci, Umut
    Uner, Aytug
    Dursun, Ayse
    Atak, Ecine Yesim
    Buyukberber, Suleyman
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (05) : 416 - 421
  • [50] Expression of HER2 in human gastric cancer cells directly correlates with antitumor activity of a recombinant disulfide-stabilized anti-HER2 immunotoxin
    Shinohara, H
    Morita, S
    Kawai, M
    Miyamoto, A
    Sonoda, T
    Pastan, I
    Tanigawa, N
    JOURNAL OF SURGICAL RESEARCH, 2002, 102 (02) : 169 - 177
12345